Thomas Stankovich - Oct 1, 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Chief Financial Officer
Signature
/s/ Thomas Stankovich
Stock symbol
RSLS
Transactions as of
Oct 1, 2021
Transactions value $
-$10,102
Form type
4
Date filed
10/12/2021, 07:40 PM
Previous filing
Aug 31, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Sale -$10.1K -3.66K -1.02% $2.76 354K Oct 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover taxes in connection with the vesting of restricted stock units.